UTILITY OF CIRCULATING TUMOR DNA (CTDNA) FROM CEREBROSPINAL FLUID (CSF) FOR PROGNOSIS OF PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA

被引：0

作者：

Miller, Alexandra M. ^{[1
]}

Nandakumar, Subhiksha ^{[2
]}

Holle, Bridget M. ^{[2
]}

Kreitzer, Christoph ^{[3
]}

Song, Timothy ^{[3
]}

Tartaro, Marlene ^{[2
]}

Hertz, Charli Ann J. ^{[2
]}

Rafailov, Johnathan ^{[3
]}

Campos, Carl ^{[2
]}

Brannon, A. Rose ^{[3
]}

Solit, David B. ^{[3
]}

Pasquini, Luca ^{[4
]}

Meng, Alicia ^{[5
]}

Reiner, Anne ^{[6
]}

Young, Robert ^{[5
]}

Socci, Nicholas D. ^{[3
]}

Arcila, Maria E. ^{[3
]}

Berger, Michael F. ^{[3
]}

Schultz, Nikolaus ^{[1
,3
]}

Mellinghoff, Ingo K. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY USA

[2] Sloan Kettering Inst, Human Oncol & Pathogenesis Program, New York, NY USA

[3] Marie Josee & Henry R Kravis Ctr Mol Oncol, New York, NY USA

[4] Weill Cornell Med Ctr, Dept Pharmacol, New York, NY USA

[5] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY USA

[6] Dept Epidemiol & Biostat, New York, NY USA

来源：

NEURO-ONCOLOGY | 2024年 / 26卷

关键词：

D O I：

10.1093/neuonc/noae165.0120

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

BIOM-48.

引用

页数：1

共 50 条

[41] Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumab
Siegal, Tali
Charbit, Hanna
Paldor, Iddo
Zelikovitch, Bracha
Canello, Tamar
Benis, Arriel
Wong, Michael L.
Morokoff, Andrew P.
Kaye, Andrew H.
Lavon, Iris
JOURNAL OF NEUROSURGERY, 2016, 125 (04) : 1008 - 1015
[42] In Reply: Reoperation for Recurrent High-Grade Glioma: Does Tumor Genetics Play a Role?
Hervey-Jumper, Shawn L.
Berger, Mitchel S.
NEUROSURGERY, 2015, 76 (04) : E497 - E497
[43] Intravoxel incoherent motion for differentiating residual/recurrent tumor from post-treatment change in patients with high-grade glioma
Tunlayadechanont, Padcha
Panyaping, Theeraphol
Chansakul, Thanissara
Hirunpat, Pornrujee
Kampaengtip, Adun
NEURORADIOLOGY JOURNAL, 2023, 36 (06): : 657 - 664
[44] SPEECH AND LANGUAGE DISORDERS IN PATIENTS WITH HIGH-GRADE GLIOMA AND ITS INFLUENCE ON PROGNOSIS
THOMAS, R
OCONNOR, AM
ASHLEY, S
JOURNAL OF NEURO-ONCOLOGY, 1995, 23 (03) : 265 - 270
[45] Phase II study of sunitinib malate in patients with recurrent high-grade glioma
Neyns, B.
Sadones, J.
Chaskis, C.
Dujardin, M.
Everaert, H.
Lv, S.
Duerinck, J.
Tynninen, O.
Nupponen, N.
Michotte, A.
De Greve, J.
JOURNAL OF NEURO-ONCOLOGY, 2011, 103 (03) : 491 - 501
[46] Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma
Hau, P
Fabel, K
Baumgart, U
Rümmele, P
Grauer, O
Bock, A
Dietmaier, C
Dietmaier, W
Dietrich, J
Dudel, C
Hübner, F
Jauch, T
Drechsel, E
Kleiter, I
Wismeth, G
Zellner, A
Brawanski, A
Steinbrecher, A
Marienhagen, J
Bogdahn, U
CANCER, 2004, 100 (06) : 1199 - 1207
[47] Therapeutic options for recurrent high-grade glioma in adult patients: Recent advances
Nieder, Carsten
Adam, Markus
Molls, Michael
Grosu, Anca L.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 (03) : 181 - 193
[48] Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma
Franceschi, E
Cavallo, G
Scopece, L
Paioli, A
Pession, A
Magrini, E
Conforti, R
Palmerini, E
Bartolini, S
Rimondini, S
Esposti, RD
Crinó, L
BRITISH JOURNAL OF CANCER, 2004, 91 (06) : 1038 - 1044
[49] Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma
E Franceschi
G Cavallo
L Scopece
A Paioli
A Pession
E Magrini
R Conforti
E Palmerini
S Bartolini
S Rimondini
R Degli Esposti
L Crinò
British Journal of Cancer, 2004, 91 : 1038 - 1044
[50] A phase II study of paclitaxel in chemonaive patients with recurrent high-grade glioma
Postma, TJ
Heimans, JJ
Luykx, SA
van Groeningen, CJ
Beenen, LFM
Hoekstra, OS
Taphoorn, MJB
Zonnenberg, BA
Klein, M
Vermorken, JB
ANNALS OF ONCOLOGY, 2000, 11 (04) : 409 - 413

← 1 2 3 4 5 →